The “Regenerative Medicines: Bone and Joint Applications” report has been added to ResearchAndMarkets.com’s offering. The global market for regenerative medicine…
Category: Health care @IT
Virtual Assistant Market size to grow by USD 26,945.07 million from 2022 to 2027; Growth driven by the growing need for automated medical transcripts – Technavio
The virtual assistant market size is set to grow by USD 26945.07 million from 2022 to 2027 progressing at a…
Global Laboratory Automation Market Report 2023: Sector is Expected to Reach $8.85 Billion in 2030 at a CAGR of 5.3%
The “Laboratory Automation Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The…
Spectros Medical Devices Pioneers Tissue Monitoring Technology
Spectros Medical Devices, a leader in non-invasive sensing and remote monitoring, has pioneered a groundbreaking technology…
Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it will host an education session for…
Remix Therapeutics to Present at Jefferies Healthcare Conference
Remix Therapeutics (Remix), a biotechnology company developing small molecule therapies to modulate RNA processing and address…
CULT Food Science Announces “Sprinkles” Pet Performance Supplement Details
CULT Food Science Corp. (“CULT” or the “Company”) (CSE: CULT) (OTC: CULTF) (FRA: LN0), a pioneer in the…
Global Healthcare Interoperability Solutions Market Report 2023: Government Initiatives to Enhance Patient Care and Safety Fuel the Sector
The “Healthcare Interoperability Solutions Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers…
CureScience™ Institute Summer Scholar Bioinformatics Training Program
CureScience™ Institute, a San Diego, California based non-profit 501(c)(3) dedicated to accelerating cures based on a combination of…
Abbott Unveils Late-Breaking Data Showing the World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
Abbott (NYSE: ABT) today announced late-breaking results from the AVEIR™ dual-chamber (DR) i2i™ Investigational Device Exemption (IDE) study,…